Evidence map›Paper›PMID 32358582›Full record

ArticleNature communications2020

Real-time monitoring of PARP1-dependent PARylation by ATR-FTIR spectroscopy.

Annika Krüger, Alexander Bürkle, Karin Hauser, Aswin Mangerich

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Single-molecule analysis of PARP1-G-quadruplex interaction.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. PARP Inhibitors: Clinical Limitations and Recent Attempts to Overcome Them.International journal of molecular sciences · 2022
    Review
  20. Fueling genome maintenance: On the versatile roles of NADThe Journal of biological chemistry · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Annika KrügerDepartment of Biology, University of Konstanz, Konstanz, 78464, Germany.
Alexander BürkleDepartment of Biology, University of Konstanz, Konstanz, 78464, Germany.
Karin HauserDepartment of Chemistry, University of Konstanz, Konstanz, 78464, Germany. karin.hauser@uni-konstanz.de.
Aswin MangerichDepartment of Biology, University of Konstanz, Konstanz, 78464, Germany. aswin.mangerich@uni-konstanz.de.ORCID http://orcid.org/0000-0001-9742-2338
University of Konstanz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poly-ADP-ribosylation (PARylation) is a fully reversible post-translational modification with key roles in cellular physiology. Due to the multi-domain structure of poly(ADP-ribose) polymerase-1 (PARP1) and the highly dynamic nature of the PARylation reaction, studies on the biochemical mechanism and structural dynamics remain challenging. Here, we report label-free, time-resolved monitoring of PARP1-dependent PARylation using ATR-FTIR spectroscopy. This includes PARP1 activation by binding to DNA strand break models, NAD

Indexed as

DNA Breaks, Double-StrandedDNA Breaks, Single-StrandedHumansKineticsNADOligonucleotidesPoly (ADP-Ribose) Polymerase-1Poly ADP RibosylationProtein BindingProtein Processing, Post-TranslationalProtein Structure, SecondarySpectroscopy, Fourier Transform Infraredadenosine 5'-(alpha-thio)diphospho-5'-ribofuranosylnicotinamideNADOligonucleotidesPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1

Identifiers

PMID32358582
PMCPMC7195430
OpenAlexW3022137877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.